Evolent Health Reports EBITDA Boost from Maturing Aetna and Highmark Relationships
1 report, 1 independent
Updated Fri 21:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Evolent Health reported that maturing relationships with Aetna and Highmark are expected to boost EBITDA. A Truist analyst raised their rating, stating that US$150 million of 2027 EBITDA is now more achievable due to these relationships. The analyst also noted that Evolent Health's growth has accelerated, even as its adjusted profit margin has narrowed.
From finchannel.com
Why it matters
The maturation of these contracts is expected to improve Evolent Health's profitability outlook. The analyst noted that concerns regarding proposed health-policy changes have been applied too broadly to the company.
From finchannel.com
Who's involved
Keep exploring
The entities involved
-
Aetna
American managed health care company
-
Highmark
for-profit insurance company in Pittsburgh, United States